Literature DB >> 3112703

Passive transfer of resistance to mice with sera from rabbits, rats or mice vaccinated with ultraviolet-attenuated cercariae of Schistosoma japonicum.

N A Moloney, P Hinchcliffe, G Webbe.   

Abstract

All serum transfers from donor rats or rabbits given single or multiple vaccinations of ultraviolet (u.v.)-attenuated Schistosoma japonicum cercariae conferred significant resistance against challenge to mice. Donors given 5 vaccinations, however, produced the most effective sera; rat sera giving up to 88% protection and rabbit sera up to 80%. This protective effect was species-specific and titratable. Sera from vaccinated rabbits and rats were were most effective when transferred to mice 2 h before challenge, but became progressively less effective when transferred with increasing time after challenge. These sera had no efficacy when given 6 days after challenge. Thus, sera from vaccinated rabbits and rats were effective against the early stage of migration, but did not necessarily have to act in the skin as all serum transfers were as effective against intraperitoneal as percutaneous challenge. By contrast, serum from multiply vaccinated mice had little or no protective effect when transferred to mice before challenge, but conferred 62% resistance when transferred 5 days after challenge. Further, there was an additive protective effect when vaccinated rat and mouse sera were given in combination at their optimum transfer times (days 0 and +5, respectively). Thus, there appears to be a stage-specific immune response induced by vaccination depending upon whether the vaccinated hosts are truly permissive or not. Vaccinated rats and rabbits respond to the early phase of migration and vaccinated mice make protective responses against the lung phase of migration.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3112703     DOI: 10.1017/s0031182000055840

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  5 in total

1.  Specific humoral response of hosts with variable schistosomiasis susceptibility.

Authors:  Patrick Driguez; Hamish E G McWilliam; Soraya Gaze; David Piedrafita; Mark S Pearson; Rie Nakajima; Mary Duke; Angela Trieu; Denise L Doolan; Fernanda C Cardoso; Algis Jasinskas; Geoffrey N Gobert; Philip L Felgner; Alex Loukas; Els Meeusen; Donald P McManus
Journal:  Immunol Cell Biol       Date:  2015-06-05       Impact factor: 5.126

2.  Correlation between bioluminescence and bacterial burden in passively protected mice challenged with a recombinant bioluminescent M49 group A streptococcus Strain.

Authors:  Meru Sheel; Manisha Pandey; Michael F Good; Michael R Batzloff
Journal:  Clin Vaccine Immunol       Date:  2009-11-04

3.  Molecular characterization of a calcium-binding protein SjCa8 from Schistosoma japonicum.

Authors:  Shaomin Hu; Pui ki Law; Zhiyue Lv; Zhongdao Wu; Ming Chiu Fung
Journal:  Parasitol Res       Date:  2008-07-12       Impact factor: 2.289

4.  Differential recognition patterns of Schistosoma haematobium adult worm antigens by the human antibodies IgA, IgE, IgG1 and IgG4.

Authors:  F Mutapi; C Bourke; Y Harcus; N Midzi; T Mduluza; C M Turner; R Burchmore; R M Maizels
Journal:  Parasite Immunol       Date:  2011-03       Impact factor: 2.280

5.  Expression and immune characterization of a novel enzyme, protein arginine methyltransferase 1, from Schistosoma japonicum.

Authors:  Wei Diao; Hejun Zhou; Wei Pan; Haipeng Liu; Yujuan Shen; Yuxin Xu; Xiaohong Li; Jianping Cao
Journal:  Parasitol Res       Date:  2013-12-17       Impact factor: 2.289

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.